Cover - shares	9 Months Ended
	Sep. 30, 2024	Nov. 08, 2024
Entity Information [Line Items]
Document Type	10-Q/A
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity Registrant Name	Microvast Holdings, Inc.
Entity Incorporation, State or Country Code	DE
Entity File Number	001-38826
Entity Tax Identification Number	83-2530757
Entity Address, Address Line One	12603 Southwest Freeway
Entity Address, Address Line Two	Suite 300
Entity Address, City or Town	Stafford
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	77477
City Area Code	(281)
Local Phone Number	491-9505
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		323,815,298
Entity Central Index Key	0001760689
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Amendment Flag	true
Amendment Description	EXPLANATORY NOTEMicrovast Holdings, Inc. (the “Company,” “we,” “us,” or “our”) is filing this Amendment No. 1 on Form 10-Q/A (this “Amendment”) to amend our Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, originally filed with the Securities and Exchange Commission (the “SEC”) on November 12, 2024 (the “Original Form 10-Q”). The Company is filing this Amendment to restate its unaudited consolidated financial statements, financial data, and related disclosures as of and for the three and nine-month period ended September 30, 2024 (the “Restatement”), to reflect an adjustment to the previously recorded impairment associated with the Company’s industrial facility located in Clarksville, Tennessee (the “Clarksville Property”), as discussed below.Restatement of Previously Issued Unaudited Consolidated Financial StatementsThis Amendment is being filed concurrently with Amendment No. 1 to the Company’s Form 10-Q for the quarter ended June 30, 2024, to reflect the impact of the Restatement related to the impairment charge associated with the Clarksville Property. During the year-end closing process, the Company identified a discrepancy in its Q2 2024 impairment assessment related to the Clarksville Property. A third-party valuation had been conducted at the time for the asset group of the Clarksville Property including building and auxiliary machinery such as clean rooms and other assets. However, in calculating the carrying value of the asset group, the Company inadvertently excluded the clean rooms from the calculation. Since the carrying value of the asset group did not reflect the full asset base, the excess amount of carrying value over fair value was understated, leading to an understatement of the impairment charge recorded in the three-month period ended June 30, 2024.To correct this error, the Company increased the impairment charge related to the Clarksville Property for the three-month period ended June 30, 2024 by $23.1 million, increasing the total impairment charge from $64.9 million to $88.0 million. This adjustment aligns the carrying value of the Clarksville Property with the valuation scope of the third-party appraisal and ensures consistency in the impairment assessment. The adjustment was fully recognized in the restated Q2 2024 financial statements and impacts the cumulative results for the nine months ended September 30, 2024.Accordingly, this Amendment reflects the corrected impairment charge for the year-to-date period through September 30, 2024, and updates all affected financial statements, footnotes and related disclosures to ensure consistency with the Q2 2024 Restatement.As discussed in Note 2 to the financial statements included in this Amendment, the Restatement does not affect the Company’s ongoing operations or liquidity.The effects of the Restatement on the unaudited consolidated financial statements as of and for the three and nine-month period ended September 30, 2024, are as follows:In thousands of U.S. dollars, except per share dataNine Months Ended September 30, 2024As ReportedAs RestatedStatement of IncomeImpairment loss of long-lived assets(64,924)(88,039)Net loss(90,019)(113,134)Net loss per common shareNet loss(90,019)(113,134)Basic and diluted$(0.28)$(0.36)Statement of Cash FlowsNet loss(90,019)(113,134)Impairment loss from long-lived asset64,924 88,039 Three Months Ended September 30, 2024Accumulateddeficit Statements of Changes in Shareholders' EquityAs ReportedAs RestatedBalance as of June 30, 2024(1,000,767)(1,023,882)Net profit13,247 13,247 Balance as of September 30, 2024(987,520)(1,010,635)Nine Months Ended September 30, 2024Accumulated deficit Statements of Changes in Shareholders' EquityAs ReportedAs RestatedBalance as of December 31, 2023(897,501)(897,501)Net loss(90,019)(113,134)Balance as of September 30, 2024(987,520)(1,010,635)September 30, 2024Balance SheetAs ReportedAs RestatedProperty, plant and equipment, net527,160 504,045 Accumulated deficit(987,520)(1,010,635)
Common Stock
Entity Information [Line Items]
Title of 12(b) Security	Common stock, par value $0.0001 per share
Trading Symbol	MVST
Security Exchange Name	NASDAQ
Warrants
Entity Information [Line Items]
Title of 12(b) Security	Redeemable warrants, exercisable for shares of common stock
Trading Symbol	MVSTW
Security Exchange Name	NASDAQ